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The Pathophysiology of ARDS
Brittney Nessle, RN, BSN
Otterbein University, Westerville, Ohio
Underlying Pathophysiology

ARDS Patient Presentation
Introduction
Acute respiratory distress syndrome
(ARDS) is a progressive life-threatening
disease process, having an occurrence of
up to 200,000 cases annually in the United
States (Schreiber, 2018). The definition of
ARDS has changed throughout the years.
In 2011, the European Society of Intensive
Care Medicine officially proposed the now
adopted Berlin ARDS definition. The
components within the definition include
timing, chest radiography, the origin of
edema, and severity of hypoxemia
(Modrykamien & Gupta, 2015). There are
over 50 different conditions that result in
injury to the alveolar-capillary membrane
that can lead to ARDS and produce several
severe complications, including death. The
diagnoses of ARDS can be difficult to
determine, thus subsequently ending in a
30-50% mortality rate (Schreiber, 2018).
ARDS is a common finding in the
Intensive Care Unit (ICU) at within
hospitals in Columbus, Ohio, and in
Intensive Care Units worldwide. It is
essential for the nurses who take direct
care of these patients to fully understand
the mechanisms behind this complication,
as early detection and treatment are
imperative.
The purpose of this poster is to explain
the presentation and pathophysiology
behind ARDS and emphasize the nurse’s
role within prevention and treatment
options.

Scenario
An 85 year old, obese, African American, male presented to the Emergency Department
in Columbus, Ohio with shortness of breath, a productive cough, and periods of dizziness
for over a week. The nurse assessed the patient as pale and diaphoretic. The patient did
claim a history of pancreatitis, COPD, diabetes, hypertension, 30 years of smoking two
packs of cigarettes a day, current everyday alcohol drinker, and receiving radiation
therapy for esophageal cancer. Patient states that he has been having trouble swallowing
certain foods since radiation.
Vital signs were obtained by the nurse, and the patient’s heart rate revealed 130 beats
per minute, oral temperature was 102.3 degrees Fahrenheit, blood pressure 90/42,
oxygen saturation 85%, and respirations 38. The patient did appear to be using accessory
muscles while breathing, therefore a nasal cannula was placed on 3L to obtain an oxygen
saturation above 90%. The nurse quickly established IV access and obtained routine labs.
A chest x-ray discovered bilateral pulmonary infiltrates (see image in bottom left corner).
The arterial blood gas (ABG) showed: pH 7.12, pCO2 60, HCO3 26 determining the
patient was experiencing respiratory acidosis. The patient’s work of breathing started to
increase after several hours, therefore the patient was rapidly placed on a mechanical
ventilator and sent to the ICU for further management.
The patient was determined to be septic due to pneumonia from aspiration and in the
proliferative phase of ARDS. Sepsis is the most common cause of ARDS (Modrykamien &
Gupta, 2015). Over the next ten days in the ICU the medical team worked diligently to
save this patient’s quality of life (see nursing implication column). The nurses monitored
the patient’s vital signs, labs, and fluid status. The nurses flipped the patient from supine
position to prone positioning. Approximately, two-thirds of patients with ARDS
demonstrate better oxygenation and ventilation from prone positioning (Drahnak &
Custer, 2015). However, the disease progressed, and the patient passed away. Mortality
in patients experiencing sepsis with ARDS is 40.6%. The male gender, African American
race, high body-mass index, and history of alcoholism are associated with a higher
mortality rate (Modrykamien & Gupta, 2015).

Clinical Manifestations
Exudative or
Inflammatory

Phases

Proliferative

Early stage of ARDS in the
exudative phase is associated
with diffuse alveolar damage,
neutrophil infiltrate, hemorrhage
and the accumulation of a
protein-rich pulmonary edema
Image citation: Fudala, R., Krupa, A., Stankowska, T.
(2010). Does activation of the FcyRlla play a role in the
Pathogenesis of the acute lung injury/acute respiratory
distress syndrome? Clinical Science, 118(8). Retrieved
from http://www.clinsci.org/content/118/8/519

ARDS is a progressive disease that can be categorized into three different phases according to the now
adopted Berlin definition (Butt et al, 2016). See algorithm below for a quick version of significant
pathophysiology events.
1. The first phase called the acute exudative phase begins one to seven days after the initial lung injury.
After the injury occurs, the body releases a systemic immune response and triggers inflammatory
mediators called cytokines. This response causes the pulmonary vasculature to become permeable
and release extra fluid into the lungs. Fluid in the lungs increase, leading to other issues. Noncardiogenic pulmonary edema occurs within the alveoli, causing the blood to leave the heart without
being oxygenated (hypoxemia). At this point, increasing the oxygen dose does not improve overall
oxygenation status (refractory hypoxemia) causing a lack of oxygen to the tissues (hypoxia). The
surfactant in the lungs decrease and the alveolae begin to collapse causing compromised gas
exchange. These events cause the patient’s work of breathing to increase. Some patients can recover
during this phase, but others will progress to the next phase.
2. The second phase called the proliferative phase happens during day seven to 14 after the initial
injury. The compromised gas exchange gets worse, causing increasing refractory hypoxemia with
tissue injury and scarring. As the body attempts to compromise, the vasculature constricts resulting
in pulmonary hypertension and right sided heart failure.
3. The final phase of ARDS happens during days 14-21. It is called the fibrotic phase because the lungs
are grossly compromised by thick pulmonary fibrosis. All previous mechanisms worsen and the
patient begins to have multi organ failure. It is during this phase that the patient may require
mechanical ventilation for a long period, and may never be able to recover (Schreiber, 2018).

Fibrotic

Dyspnea and hypoxemia with poor response to oxygen supplementation
Timeline

Within 72 Hours
▪
▪
▪
▪
▪
▪

Chest x-ray of patient showing
bilateral pulmonary infiltrates
Image citation: Horlander, K. T. (2016). Imaging in
Acute Respiratory Distress Syndrome. Retrieved
July 19, 2019, from
https://emedicine.medscape.com/article/362571overview#a2

Dyspnea
Tachypnea
Tachycardia
Pallor
Mild Hypoxia
Clinical
Respiratory
Manifestations
Alkalosis
▪ Bilateral
pulmonary
infiltrates on
chest x-ray
▪ Diaphoresis

4 to 21 Days
▪ Increased work of
breathing
▪ Dyspnea
▪ Tachypnea
▪ Tachycardia
▪ Refractory hypoxemia
▪ Respiratory alkalosis
▪ Increased bilateral
pulmonary infiltrates
on chest x-ray
▪ Pulmonary
hypertension
▪ Right heart failure
▪ Pulmonary fibrosis
▪ Hypercarbia

Significance of Pathophysiology
It is evident that early recognition of ARDS is crucial. If ARDS is
detected and treated in the early phase, then that could
prevent the disease from progressing and ultimately avoid
death. Diagnosis is made due to evidence of lung injury,
physical assessment, ABG analysis, and chest radiographs
(McCance & Huether, 2018). It is critical that health care
providers understand the underlying pathophysiology and
diagnosis to pinpoint signs and symptoms of ARDS.

Implications for Nursing Care
▪ Frequent respiratory assessment
▪ Frequent evaluation of vital signs, especially respiratory
rate, oxygen saturation
▪ Arterial blood gas interpretation
▪ Aseptic techniques and infection with any nursing care
▪ Assess for cardiac dysrhythmias and signs for decreased
cardiac output
▪ Monitor routine labs and replace electrolyte imbalances
▪ Medication therapy may include but not limited to:
antibiotics, bronchodilators, vasopressors, diuretics,
anxiolytics, analgesics, sedatives, and neuro-muscular
blockade.
▪ Manage mechanical ventilator with higher PEEP (Del Sorbo
et al, 2017)
▪ Frequent aseptic oral care while on ventilator
▪ Dietary consult and manage possible tube feeding
▪ Blood product administration techniques
▪ Daily weight
▪ Strict input and output
▪ Prone positioning
▪ Elevating head of bed
▪ Managing secretions adequately
▪ Emotional support to manage fear and anxiety for patient
and family involved
▪ Education on risk factors, including but not limited to
smoking and alcohol sensation, and vaccinations
(Schreiber, 2018, p. 60)

14 to 21 Days
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪

Profound respiratory distress
Critical refractory hypoxemia
Cyanosis
Mental status change
White lung on chest x-ray
Pulmonary hypertension
Right heart failure
Dense fibrotic tissue
Hypercarbia
Death

Hyperventilation and respiratory alkalosis

Conclusion

Decreased tissue perfusion, metabolic acidosis, and organ dysfunction
Increased work of breathing, decreased tidal volume, and
hypoventilation
Hypercapnia, respiratory acidosis, and worsening hypoxemia

(Schreiber, 2018, p. 60)

Decreased cardiac output, hypotension, death
(McCance & Huether, 2018, p. 3732)

Acute respiratory distress syndrome is a critical respiratory
disease that progresses quickly through three different
phases. If prevented or recognized early, the patient will
experience a promising outcome. Additionally, there are
current studies investigating new ways and strategies to treat
ARDS. Some possibilities being tested include gene therapy,
prophylactic immunotherapy, surfactant replacement,
various immunotherapy mediators, stem cell replacements,
among several other therapies (McCance & Huether, 2018). It
is imperative that all heath care providers understand signs,
nursing implications for early detection and ongoing
advancements for the best treatment available.
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